Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Hypotension D007022 41 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hyperalgesia D006930 42 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Fatty Liver D005234 48 associated lipids
Thrombosis D013927 49 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Katz JM et al. Inhibition of prostaglandin action and bone resorption by copper. 1984 Ann. Rheum. Dis. pmid:6441529
Pedersen AK et al. Inhibition of thromboxane biosynthesis in serum: limitations of the measurement of immunoreactive 6-keto-PGF1 alpha. 1984 Thromb. Res. pmid:6546456
Novo S et al. Platelet activity in relation to smoke and exercise in patients with chronic obstructive lung disease: effects of platelet antiaggregating drugs. 1984 Adv. Exp. Med. Biol. pmid:6546467
Ford WD et al. Congenital diaphragmatic hernia: association between pulmonary vascular resistance and plasma thromboxane concentrations. 1984 Arch. Dis. Child. pmid:6546658
Le Breton GC et al. 2-(6-carboxyhexyl)cyclopentanone hexylhydrazone: a potent inhibitor of the blood platelet cyclo-oxygenase. 1984 Prostaglandins pmid:6427851
Schwartz D et al. Renal arachidonic acid metabolism and cellular changes in the rabbit renal vein constricted kidney: inflammation as a common process in renal injury models. 1984 Prostaglandins pmid:6427853
Mitsuhashi N and Kato J Bioconversion of arachidonic acid to prostaglandins and related compounds in human myometrium and uterine cervix. 1984 Endocrinol. Jpn. pmid:6442700
Heinonen PK and Metsä-Ketelä T Prostaglandin and thromboxane production in ovarian cancer tissue. 1984 Gynecol. Obstet. Invest. pmid:6396175
Gachályi B et al. In vitro effect of cimetidine on ADP induced platelet aggregation and thromboxane A2 synthesis in man. 1984 Thromb. Res. pmid:6474407
Fitzpatrick F et al. Development of a gas chromatographic-mass spectrometric method using a stable isotope internal standard for quantitation of thromboxane B2. 1984 Thromb. Res. pmid:6474413
Watanabe J et al. Effect of vitamin E on platelet aggregation in diabetes mellitus. 1984 Tohoku J. Exp. Med. pmid:6474447
Triolo G et al. Circulating immune complexes and platelet thromboxane synthesis in patients with insulin-dependent (type I) diabetes mellitus. 1984 Diabetes pmid:6611280
Salmon JA et al. Benoxaprofen does not inhibit formation of leukotriene B4 in a model of acute inflammation. 1984 Biochem. Pharmacol. pmid:6089840
Girotti MJ et al. Effects of immunization on cardiopulmonary alterations of gram-negative endotoxemia. 1984 J Appl Physiol Respir Environ Exerc Physiol pmid:6368499
Pan IQ et al. Alteration of platelet responses to metabolites of arachidonic acid by oral contraceptives. 1984 Br. J. Haematol. pmid:6089860
Serhan CN et al. Formation of leukotrienes and hydroxy acids by human neutrophils and platelets exposed to monosodium urate. 1984 Prostaglandins pmid:6328582
Zipser RD et al. Therapeutic trial of thromboxane synthesis inhibition in the hepatorenal syndrome. 1984 Gastroenterology pmid:6593268
Koskimies AI et al. Peritoneal fluid 6-keto-prostaglandin F1 alpha, thromboxane B2 in endometriosis and unexplained infertility. 1984 Acta Obstet Gynecol Scand Suppl pmid:6594012
Branski D et al. Prostaglandins in small intestinal mucosa of children with celiac disease. 1984 J. Pediatr. Gastroenterol. Nutr. pmid:6594493
Woodcock BE et al. The platelet defect in acute myeloid leukaemia. 1984 J. Clin. Pathol. pmid:6595273
Holgate ST et al. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release. 1984 J. Immunol. pmid:6206153
Zimmermann I et al. [Influence of vagus nerve, histamine, prostaglandin and catecholamine on airway obstruction]. 1984 Respiration pmid:6473921
Chan CC et al. Inhibition of prostanoid-mediated platelet aggregation in vivo and in vitro by 3-hydroxymethyl-dibenzo(b,f)thiepin 5,5-dioxide (L-640,035). 1984 J. Pharmacol. Exp. Ther. pmid:6423813
Hall ER et al. The reduction of potential TXB2 levels when serum is preincubated at room temperature. 1984 Prostaglandins Leukot Med pmid:6585846
Codde JP et al. Validation of the direct radioimmunoassay of prostanoids in serum and kidney. 1984 Prostaglandins Leukot Med pmid:6587406
Shaala S et al. Local effect of thromboxane B2 on the contractility of the human non pregnant uterus. 1984 Prostaglandins Leukot Med pmid:6587408
Marks JG et al. Contact urticaria and airway obstruction from carbonless copy paper. 1984 Aug 24-31 JAMA pmid:6235381
MacNab MW et al. The effects of a new thromboxane synthetase inhibitor, CGS-13080, in man. 1984 Feb-Mar J Clin Pharmacol pmid:6371062
Buchanan MR and Hirsh J Effect of aspirin and salicylate on platelet-vessel wall interactions in rabbits. 1984 Jul-Aug Arteriosclerosis pmid:6380468
Paajanen H et al. Modification of platelet aggregation and thromboxane synthesis by intravascular contrast media. 1984 Jul-Aug Invest Radiol pmid:6434489
De Caterina R et al. Thromboxane-B2 generation during ex-vivo platelet aggregation. 1984 Jul-Sep J. Nucl. Med. Allied Sci. pmid:6530623
Egg D Concentrations of prostaglandins D2, E2, F2 alpha, 6-keto-F1 alpha and thromboxane B2 in synovial fluid from patients with inflammatory joint disorders and osteoarthritis. 1984 Mar-Apr Z Rheumatol pmid:6730731
Tanabe M et al. Inhibition of coronary circulatory failure and thromboxane A2 release during coronary occlusion and reperfusion by 2-phenylaminoadenosine (CV-1808) in anesthetized dogs. 1984 May-Jun J. Cardiovasc. Pharmacol. pmid:6202970
Laustiola K et al. Exercise-induced increase in plasma arachidonic acid and thromboxane B2 in healthy men: effect of beta-adrenergic blockade. 1984 May-Jun J. Cardiovasc. Pharmacol. pmid:6202971
Sturm M et al. The measurement of plasma thromboxane B2 and the effect of smoking. 1984 Nov-Dec Clin. Exp. Pharmacol. Physiol. pmid:6536421
Menitove JE et al. Use of prostacyclin to inhibit activation of platelets during preparation of platelet concentrates. 1984 Nov-Dec Transfusion pmid:6390814
Fisher M et al. Selective thromboxane inhibition: a new approach to antiplatelet therapy. 1984 Sep-Oct Stroke pmid:6474531
Uderman HD et al. Thromboxane synthetase inhibitor UK38,485 lowers blood pressure in the adult spontaneously hypertensive rat. 1984 Sep-Oct J. Cardiovasc. Pharmacol. pmid:6209508
Hänsch GM et al. Induction of prostanoid synthesis in human platelets by the late complement components C5b-9 and channel forming antibiotic nystatin: inhibition of the reacylation of liberated arachidonic acid. 1985 J. Immunol. pmid:2409145
Yajima M et al. Plasma thromboxane B2, 6-keto PGF1 alpha and cyclic nucleotides levels as related to treadmill exercise test in patients with ischemic heart disease. 1985 Jpn. Circ. J. pmid:2982050
Fiedler VB et al. Leukotrienes on porcine hemodynamics and prostanoid release. 1985 Int. J. Cardiol. pmid:2993176
Ment LR et al. Randomized indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight infants. 1985 J. Pediatr. pmid:3906073
Kobayashi H et al. Effects of 6-keto-prostaglandin E1 on ascitic hepatoma-130 in vivo comparison with chemotherapeutic agents. 1985 Prostaglandins pmid:3920729
Quilley J and McGiff JC Arachidonic acid metabolism and urinary excretion of prostaglandins and thromboxane in rats with experimental diabetes mellitus. 1985 J. Pharmacol. Exp. Ther. pmid:3925127
Powell AM et al. Menstrual-PGF2 alpha, PGE2 and TXA2 in normal and dysmenorrheic women and their temporal relationship to dysmenorrhea. 1985 Prostaglandins pmid:3856904
Glance DG et al. Prostaglandin production and stimulation by angiotensin II in the isolated perfused human placental cotyledon. 1985 Am. J. Obstet. Gynecol. pmid:3855602
Numano F et al. Prostacyclin and variant angina. 1985 Ann. N. Y. Acad. Sci. pmid:3865605
Wang JP et al. Antiplatelet effect of hsien-ho-t'sao (Agrimonia pilosa). 1985 Am. J. Chin. Med. pmid:3927704
Safai-Kutti S et al. Impaired in vivo platelet reactivity in infantile autism. 1985 Acta Paediatr Scand pmid:2931944
Meese CO et al. Measurement of thromboxane B2 in human urine by isotope dilution and negative ion chemical ionization mass spectrometry. 1985 Biomed. Mass Spectrom. pmid:2932184
Boss AH et al. Effect of incremental doses of aspirin on bleeding time, platelet aggregation and thromboxane production in patients with cerebrovascular disease. 1985 Eur. J. Clin. Invest. pmid:3938412
Ambler J et al. CGS 12970: a novel, long acting thromboxane synthetase inhibitor. 1985 Br. J. Pharmacol. pmid:2932197
Gresele P et al. Thromboxane A2 and prostacyclin do not modulate the systemic hemodynamic response to cold in humans. 1985 J. Lab. Clin. Med. pmid:2932514
Hashimoto Y et al. Time-dependent inhibition of the cyclooxygenase pathway by 12-hydroperoxy-5,8,10,14-eicosatetraenoic acid. 1985 Biochem. Biophys. Res. Commun. pmid:3927909
Mueller HS et al. Systemic and transcardiac platelet activity in acute myocardial infarction in man: resistance to prostacyclin. 1985 Circulation pmid:2933181
Hakim RM and Schafer AI Hemodialysis-associated platelet activation and thrombocytopenia. 1985 Am. J. Med. pmid:3885730
Howes EL et al. Lipopolysaccharide tolerance inhibits eye inflammation. I. Reduced immune complex or lipopolysaccharide effects. 1985 Arch. Ophthalmol. pmid:3156578
Jouppila P et al. Ritodrine infusion during late pregnancy: effects on fetal and placental blood flow, prostacyclin, and thromboxane. 1985 Am. J. Obstet. Gynecol. pmid:3885740
Velardo B and Lagarde M Differential effect of external calcium on the oxygenated metabolism of endogenous and exogenous arachidonic acid in platelets. 1985 Biochem. Biophys. Res. Commun. pmid:3927915
Davì G et al. Inhibition of platelet function by ticlopidine in arteriosclerosis obliterans of the lower limbs. 1985 Thromb. Res. pmid:2933846
Bloom A et al. Hemolytic-uremic syndrome: demonstration of abnormalities of platelet reactivity and insensitivity to prostaglandin I2. 1985 Clin. Nephrol. pmid:3886228
Janka HU Platelet and endothelial function tests during metformin treatment in diabetes mellitus (short communication). 1985 Horm. Metab. Res. Suppl. pmid:2934311
Hayashi C [Thromboxane B2 in surgery]. 1985 Nihon Geka Gakkai Zasshi pmid:2935731
Steinhauer HB et al. Thromboxane B2 and beta 2-microglobulin as early indicators of renal allograft rejection. 1985 Proc Eur Dial Transplant Assoc Eur Ren Assoc pmid:3887370
Lenhard V et al. Transfusion-induced enhancement of prostaglandin and thromboxane release in prospective kidney graft recipients. 1985 Proc Eur Dial Transplant Assoc Eur Ren Assoc pmid:3887386
Stuart MJ and Dusse J In vitro comparison of the efficacy of cyclooxygenase inhibitors on the adult versus neonatal platelet. 1985 Biol. Neonate pmid:4005330
Moncada S and Whittle BJ Biological actions of prostacyclin and its pharmacological use in platelet studies. 1985 Adv. Exp. Med. Biol. pmid:3010671
Rajtar G et al. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors. 1985 Biochem. Pharmacol. pmid:3918536
Prosdocimi M et al. Prostacyclin and thromboxane levels during cardiac ischemia in dogs. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:3159235
Stine RA et al. Failure of percutaneous transluminal coronary angioplasty to stimulate platelet and prostaglandin activity. 1985 Cathet Cardiovasc Diagn pmid:3160477
Liu MC et al. Studies of platelet hyperactivity in patients with ischemic cerebrovascular diseases. III. Platelet hyperactivation in the chronic phase of cerebral thromboembolism. 1985 Taiwan Yi Xue Hui Za Zhi pmid:3160819
Hechtman DH and Jageneau A Inhibition of cold-induced vasoconstriction with ketanserin. 1985 Microvasc. Res. pmid:3160915
Yamaguchi A et al. Effect of cetiedil on platelet aggregation and thromboxane synthesis. 1985 Thromb. Res. pmid:2986312
Utsunomiya T et al. [Circulating negative inotropic substance produced by the lung, affected by prostaglandin and thromboxane]. 1985 Nihon Geka Gakkai Zasshi pmid:3160927
Wang CB and Chang AM [Plasma thromboxane B2 changes in severe icteric hepatitis treated by traditional Chinese medicine--dispelling the pathogenic heat from blood, promoting blood circulation and administrating large doses of radix Paeoniae--a report of 6 cases]. 1985 Zhong Xi Yi Jie He Za Zhi pmid:3161645
Elliott GR et al. Differential regulation of the cyclooxygenase pathway in starch elicited rat peritoneal macrophages by prostaglandin E2, U-44069, a stable endoperoxide analogue and dibutyryl-cyclic AMP. 1985 Eur. J. Pharmacol. pmid:2995076
Weisman SM et al. Platelet-activating factor is a potent stimulus for renal prostaglandin synthesis: possible significance in unilateral ureteral obstruction. 1985 J. Pharmacol. Exp. Ther. pmid:3862805
Narita H et al. Insufficient mobilization of calcium by early breakdown of phosphatidylinositol 4,5-bisphosphate for aggregation of human platelets by collagen. 1985 J. Biochem. pmid:3001036
Garrett RC and Thomas HM Relation of prostanoids to strength of hypoxic vasoconstriction in dogs with lobar atelectasis. 1985 J. Appl. Physiol. pmid:3839788
Horiuchi Y et al. [Studies on changes in histamine levels in the blood of infants and children. Part 7. The time studies of histamine, lipoxygenase metabolites, thromboxe B2 and cyclic AMP release from human platelets and leucocytes on treadmill exercise in asthmatic children]. 1985 Arerugi pmid:3002304
Giani E et al. Heated fat, vitamin E and vascular eicosanoids. 1985 Lipids pmid:3839887
Giani E et al. Platelets from aged rats aggregate more, but are more sensitive to prostacyclin. 1985 Prostaglandins Leukot Med pmid:3003760
Ikkala E et al. Haemostatic parameters in Cushing's syndrome. 1985 Acta Med Scand pmid:4025006
Sylvester JT et al. Prostaglandins and estradiol-induced attenuation of hypoxic pulmonary vasoconstriction. 1985 Chest pmid:3840073
Seitz M and Hunstein W Enhanced prostanoid release from monocytes of patients with rheumatoid arthritis and active systemic lupus erythematosus. 1985 Ann. Rheum. Dis. pmid:4026405
Nomura S [Plasma levels of thromboxane B2 and 6-keto PGF1 alpha in patients with variant angina]. 1985 Nippon Naika Gakkai Zasshi pmid:3840191
Freund HR et al. Muscle prostaglandin production in the rat. Effect of abdominal sepsis and different amino acid formulations. 1985 Arch Surg pmid:4026556
Prosdocimi M et al. Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonyl methoxy coumarin) of platelet aggregation in dog stenosed coronary artery. 1985 Thromb. Res. pmid:3840290
Lelcuk S et al. Thromboxane A2 moderates permeability after limb ischemia. 1985 Ann. Surg. pmid:3840349
Wilson L and Huang LS Contributions of the fetoplacental unit to augmented uterine prostaglandin levels periparturition in the rat. 1985 Biol. Reprod. pmid:3840391
Chang J et al. Modulation by hydroxyeicosatetraenoic acids (HETEs) of arachidonic acid metabolism in mouse resident peritoneal macrophages. 1985 Eur. J. Pharmacol. pmid:3920057
Wong C et al. Effect of hydroxyl radical scavenging on endotoxin-induced lung injury. 1985 Surgery pmid:2983450
Ding YA et al. Potentiation of adrenaline-induced platelet aggregation by angiotensin II. 1985 Thromb. Haemost. pmid:4089801
Lawson JA et al. Measurement of urinary 2,3-dinor-thromboxane B2 and thromboxane B2 using bonded-phase phenylboronic acid columns and capillary gas chromatography--negative-ion chemical ionization mass spectrometry. 1985 Anal. Biochem. pmid:4091270
Reines HD et al. Lack of effect of glucocorticoids upon plasma thromboxane in patients in a state of shock. 1985 Surg Gynecol Obstet pmid:3983796
Alessandrini P et al. Physiologic variables affecting thromboxane B2 production in human whole blood. 1985 Thromb. Res. pmid:3983893
Fukushima M et al. [Role of thromboxane A2 in pulmonary air embolism in conscious sheep]. 1985 Kokyu To Junkan pmid:4023449
Conti P et al. Effect of supernatants from PHA-stimulated and non-stimulated lymphocyte cultures on thromboxane B2 release by polymorphonuclear leukocytes in vitro. 1985 Agents Actions pmid:4003201
Carter AJ and Hanley SP The effect of platelet number and haematocrit on whole blood thromboxane synthesis. 1985 Thromb. Haemost. pmid:4024033
Singer P et al. Blood pressure- and lipid-lowering effect of mackerel and herring diet in patients with mild essential hypertension. 1985 Atherosclerosis pmid:3000395